ADC BIO: Sterling Makes Strategic Investment in ADC Bio
Will work together to develop an integrated service offering combining ADC Bio's expertise with Sterling's high potency small molecule expertise.
Read full article »
ADC Bio is a UK-based biotechnology company that develops and commercializes antibody-drug conjugates for the treatment of cancer.
Read more